ARCHIVES

In Brief: Goldsmith Named CEO of CancerCare

This article is from The Cancer Letter archive.

Vol. 40 No. 15 | April 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007